The Role of Inflammation in Schizophrenia

The Role of Inflammation in Schizophrenia

AbstractHigh levels of pro-inflammatory substances such as cytokines have been described in the blood and cerebrospinal fluid of schizophrenia patients. Animal models of schizophrenia show that under certain conditions an immune disturbance during early life, such as an infection-triggered immune ac...

Full description

Bibliographic Details
Main Authors:	Norbert eMüller, Elif eWeidinger, Bianka eLeitner, Markus J. Schwarz
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2015-10-01
Series:	Frontiers in Neuroscience
Subjects:	Inflammation Psychoneuroimmunology Schizophrenia Neuroinflammation COX-2
Online Access:	http://journal.frontiersin.org/Journal/10.3389/fnins.2015.00372/full

Similar Items

COX-2 Inhibitors, Aspirin, and Other Potential Anti-Inflammatory Treatments for Psychiatric Disorders
by: Norbert Müller, et al.
Published: (2019-05-01)

Effects of long-term therapy with quetiapine and olanzapine on parameters of immunity and cytokine levels in patients with schizophrenia
by: O. Lobacheva, et al.
Published: (2021-04-01)

Inflammation and Depression: A Nervous Plea for Psychiatry to Not Become Immune to Interpretation
by: Jan Pieter Konsman
Published: (2019-02-01)

Biological mechanisms underlying widowhood's health consequences: Does diet play a role?
by: Christopher P. Fagundes, et al.
Published: (2021-08-01)

The role of neuroinflammation and neurovascular dysfunction in major depressive disorder
by: Jeon SW, et al.
Published: (2018-05-01)

C-Reactive Protein in Bipolar Disorder in an Indian Clinical Setting
by: Aparna Sundaresh, et al.
Published: (2018-09-01)

The origins of health and disease /
by: 526555 Hyland, Michael
Published: (c201)

Psychoneuroimmunology /
by: Ader, Robert
Published: (2007)

Neuroinflammation and schizophrenia – is there a link?
by: Cristiano Chaves, et al.
Published: (2024-02-01)

The scientific basis of integrative medicine /
by: 417742 Wisneski, Leonard A, et al.
Published: (2004)

Building a replicable and clinically-impactful immunopsychiatry: Methods, phenotyping, and theory integration
by: Daniel P. Moriarity
Published: (2021-10-01)

Chemokine Dysregulation and Neuroinflammation in Schizophrenia: A Systematic Review
by: Evgeny A. Ermakov, et al.
Published: (2023-01-01)

Dysregulation of phospholipase and cyclooxygenase expression is involved in Schizophrenia
by: Xuhan Yang, et al.
Published: (2021-02-01)

Dopaminergic Receptor Targeting in Multiple Sclerosis: Is There Therapeutic Potential?
by: Mikhail Melnikov, et al.
Published: (2021-05-01)

Neuroinflammation in Schizophrenia
by: Feytie Magda Mawey, et al.
Published: (2021-05-01)

Editorial: The Role of Inflammation in the Etiology and Treatment of Schizophrenia
by: Ole Köhler-Forsberg, et al.
Published: (2020-10-01)

The Role of Cytokines in the Pathogenesis of Schizophrenia
by: Bartosz Dawidowski, et al.
Published: (2021-08-01)

Relationship between Bipolar Disorder and Rheumatoid Arthritis
by: Melike Mandacı, et al.
Published: (2022-06-01)

The role of inflammation in acute psychosocial stress-induced modulation of reward processing in healthy female adults
by: Chloe C. Boyle, et al.
Published: (2023-03-01)

The Role of Inflammation in the Treatment of Schizophrenia
by: Guillaume Fond, et al.
Published: (2020-03-01)

Sleep Inconsistency and Markers of Inflammation
by: Joseph M. Dzierzewski, et al.
Published: (2020-09-01)

The role of infections and inflammation in schizophrenia: review of the evidence
by: Gellan K. Ahmed, et al.
Published: (2024-02-01)

IMMUNOSUPPRESSION CAUSED BY EMOTIONAL STRESS: FROM ETIOLOGY TO PATHOGENESIS
by: Thiago Soethe Ramos, et al.
Published: (2022-08-01)

Distinct Phenotypes of Inflammation Associated Macrophages and Microglia in the Prefrontal Cortex Schizophrenia Compared to Controls
by: Yunting Zhu, et al.
Published: (2022-06-01)

Clinical characteristics of bipolar 1 disorder in relation to interleukin-6: a cross-sectional study among Egyptian patients
by: May Hassan, et al.
Published: (2023-03-01)

COVID-19 and the Nervous System from a Cuban Experience
by: Maria de los Angeles Robinson-Agramonte, et al.
Published: (2023-09-01)

A Review of Postpartum Depression: Focused on Psychoneuroimmunological Interaction
by: Yunmi Kim, et al.
Published: (2015-06-01)

The Interrelation between Interleukin-2 and Schizophrenia
by: Yu Huang, et al.
Published: (2022-08-01)

Longitudinal assessment of inflammatory markers in the peripartum period by depressive symptom trajectory groups
by: Emma Bränn, et al.
Published: (2022-07-01)

Alterations in inflammasome-related immunometabolites in individuals with severe psychiatric disorders
by: Ulrika Hylén, et al.
Published: (2023-04-01)

Connecting the dots from east to west
by: Keith W. Kelley, et al.
Published: (2022-12-01)

The health consequences of stress in couples: A review and new integrated Dyadic Biobehavioral Stress Model
by: M. Rosie Shrout
Published: (2021-10-01)

The autopoiesis and the mindfulness as a tool for selfmanagement in health. A theoretical support for a clinical study in psychoneuroimmunology
by: J.T. Saavedra Perez De Arce, et al.
Published: (2021-04-01)

Is It Time for a Paradigm Shift in the Treatment of Schizophrenia? The Use of Inflammation-Reducing and Neuroprotective Drugs—A Review
by: Antonino Messina, et al.
Published: (2023-06-01)

Effects of New NSAID-CAI Hybrid Compounds in Inflammation and Lung Fibrosis
by: Laura Lucarini, et al.
Published: (2020-09-01)

Imunne system and schyzophrenia
by: A. Almeida, et al.
Published: (2022-06-01)

Schizophrenia and Inflammation Research: A Bibliometric Analysis
by: He-Li Sun, et al.
Published: (2022-06-01)

Editorial: The Different Faces of Sickness
by: Lena Rademacher, et al.
Published: (2021-08-01)

A Biopsychosocial Approach to Grief, Depression, and the Role of Emotional Regulation
by: Cristina Peña-Vargas, et al.
Published: (2021-08-01)

Counting the Toll of Inflammation on Schizophrenia—A Potential Role for Toll-like Receptors
by: Saahithh Redddi Patlola, et al.
Published: (2023-07-01)